Recent studies have raised concerns about a potential link between Ozempic (semaglutide) and serious vision problems, particularly the rare condition known as non-arteritic anterior ischemic optic neuropathy (NAION)
2026 Guideline on the Management of Dyslipidemia Updated: March 13, 2026 This guideline retires and replaces the 2018 AHA/ACC Guideline on the Management of Blood Cholesterol and is retitled the 2026 Guideline on the Management of Dyslipidemia to reflect the evolving understanding of atherosclerotic cardiovascular disease (ASCVD) risk associated with atherogenic lipoproteins beyond low-density lipoprotein cholesterol (LDL-C), including triglyceride-rich remnant particles and lipoprotein(a) [Lp(a)]
13 In addition to being recommended in patients with ASCVD, GLP-1 receptor agonists are recommended for consideration as an add-on to metformin in patients without established ASCVD in whom there is a compelling need to minimize hypoglycemia, minimize weight gain, or promote weight loss
In this section, we will explore whether people with sulfa allergies can safely take semaglutide
A recent study reported that the novel mitophagy inducer miriplatin-loaded liposomes (LMPt) enhance LONP1 binding to polymerase gamma (POLG) and TFAM, thereby resulting in POLG and TFAM degradation, which inhibits mtDNA replication and suppresses pancreatic cancer cell proliferation [160]
$150.00Purchase & earn 150 points